DocMorris AG (LON:0RRB)
5.70
-0.14 (-2.46%)
At close: Sep 26, 2025
DocMorris AG Revenue
DocMorris AG had revenue of 260.83M CHF in the quarter ending June 30, 2025, with 4.17% growth. This brings the company's revenue in the last twelve months to 1.06B, up 5.93% year-over-year. In the year 2024, DocMorris AG had annual revenue of 1.02B with 4.91% growth.
Revenue (ttm)
1.06B CHF
Revenue Growth
+5.93%
P/S Ratio
0.27
Revenue / Employee
730.56K CHF
Employees
1,454
Market Cap
263.87M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.02B | 47.58M | 4.91% |
Dec 31, 2023 | 969.46M | 38.49M | 4.13% |
Dec 31, 2022 | 930.97M | -795.53M | -46.08% |
Dec 31, 2021 | 1.73B | 249.57M | 16.90% |
Dec 31, 2020 | 1.48B | 121.39M | 8.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
DocMorris AG News
- 6 weeks ago - DocMorris AG (ZRSEF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - DocMorris AG (ZRSEF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - DocMorris AG (ZRSEF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Online drug retailer DocMorris meets expectations as cost savings help - Reuters
- 2 years ago - Online drug retailer DocMorris trims top end of 2023 outlook - Reuters
- 2 years ago - DocMorris AG (ZRSEF) Q2 2023 Earnings Call Transcript - Seeking Alpha